Tregs constitute a subpopulation of T cells that promote tumor progression, via interacting with TME components, by the expression of FOXP3 that suppresses the CD8+ T cells, as well as via releasing IL-2 that leads to NK cells’ deregulation [48]. The gene discussed is CD8A; the disease is neoplasm.